Genetic basis of persister tolerance to aminoglycosides in Escherichia coli

mBio

Volumn 6, Issue 2, 2015, Pages

  Shan, Yue ^a   Lazinski, David ^b   Rowe, Sarah ^a   Camilli, Andrew ^b   Lewis, Kim ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; GLUTAMINE; SERINE; THREONINE; TRYPTOPHAN; AMINO ACID; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; TRANSPOSON;

AMINO ACID SYNTHESIS; ARTICLE; AUXOTROPHY; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL SURVIVAL; BACTERIUM CULTURE; BACTERIUM MUTANT; CELL MATURATION; CELL MOTILITY; CELL SUBPOPULATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DRUG TOLERANCE; ESCHERICHIA COLI; FLAGELLAR GENE; GENE DELETION; GENE IDENTIFICATION; GENE LIBRARY; GENE SEQUENCE; LETHAL DOSE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; SENSITIZATION; STEADY STATE; TRANSPOSON; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LOCOMOTION;

ESCHERICHIA COLI;

AMINO ACIDS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BIOSYNTHETIC PATHWAYS; DNA TRANSPOSABLE ELEMENTS; DRUG TOLERANCE; ESCHERICHIA COLI; GENTAMICINS; LOCOMOTION; MUTAGENESIS, INSERTIONAL;

EID: 84929467281     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00078-15     Document Type: Article

References (42)

1. Lewis K. 2010. Persister cells. Annu Rev Microbiol 64:357–372. http://dx.doi.org/10.1146/annurev.micro.112408.134306.
2. Mulcahy LR, Burns JL, Lory S, Lewis K. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192:6191–6199. http://dx.doi.org/10.1128/JB.01651-09.
3. Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K, Leonard SN, Smith RD, Adkins JN, Lewis K. 2013. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503: 365–370. http://dx.doi.org/10.1038/nature12790.
4. Helaine S, Cheverton AM, Watson KG, Faure LM, Matthews SA, Holden DW. 2014. Internalization of salmonella by macrophages induces formation of nonreplicating persisters. Science 343:204-208. http://dx.doi.org/10.1126/science.1244705.
5. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105–107. http://dx.doi.org/10.1126/science.1084550.
6. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186:8172–8180. http://dx.doi.org/10.1128/JB.186.24.8172-8180.2004.
7. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: a distinct physiological state of E. coli. BMC Microbiol 6:53.
8. Germain E, Castro-Roa D, Zenkin N, Gerdes K. 2013. Molecular mechanism of bacterial persistence by HipA. Mol Cell 52:248-254. http://dx.doi.org/10.1016/j.molcel.2013.08.045.
9. Kaspy I, Rotem E, Weiss N, Ronin I, Balaban NQ, Glaser G. 2013. HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat Commun 4:3001. http://dx.doi.org/10.1038/ncomms4001.
10. Schumacher MA, Piro KM, Xu W, Hansen S, Lewis K, Brennan RG. 2009. Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323:396-401. http://dx.doi.org/10.1126/science.1163806.
11. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K. 2011. Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A 108: 13206–13211. http://dx.doi.org/10.1073/pnas.1100186108.
12. Gurnev PA, Ortenberg R, Dörr T, Lewis K, Bezrukov SM. 2012. Persister-promoting bacterial toxin TisB produces anion-selective pores in planar lipid bilayers. FEBS Lett 586:2529-2534. http://dx.doi.org/10.1016/j.febslet.2012.06.021.
13. Dörr T, Vulic´ M, Lewis K. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8:e1000317. http://dx.doi.org/10.1371/journal.pbio.1000317.
14. Hu Y, Coates AR. 2005. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiol Lett 243:117–124. http://dx.doi.org/10.1016/j.femsle.2004.11.049.
15. Hansen S, Lewis K, Vulic´ M. 2008. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 52:2718–2726. http://dx.doi.org/10.1128/AAC.00144-08.
16. Spoering AL, Vulic M, Lewis K. 2006. GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol 188:5136-5144. http://dx.doi.org/10.1128/JB.00369-06.
17. Bernier SP, Lebeaux D, DeFrancesco AS, Valomon A, Soubigou G, Coppée JY, Ghigo JM, Beloin C. 2013. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet 9:e1003144. http://dx.doi.org/10.1371/journal.pgen.1003144.
18. Van Opijnen T, Bodi KL, Camilli A. 2009. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods 6:767–772. http://dx.doi.org/10.1038/nmeth.1377.
19. Begg EJ, Barclay ML. 1995. Aminoglycosides—50 years on. Br J Clin Pharmacol 39:597–603.
20. Jackson J, Chen C, Buising K. 2013. Aminoglycosides: how should we use them in the 21st century? Curr Opin Infect Dis 26:516-525. http://dx.doi.org/10.1097/QCO.0000000000000012.
21. Davis BD. 1987. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev 51:341–350.
22. Taber HW, Mueller JP, Miller PF, Arrow AS. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 51:439–457.
23. Keseler IM, Mackie A, Peralta-Gil M, Santos-Zavaleta A, Gama-Castro S, Bonavides-Martínez C, Fulcher C, Huerta AM, Kothari A, Krummenacker M, Latendresse M, Muñiz-Rascado L, Ong Q, Paley S, Schröder I, Shearer AG, Subhraveti P, Travers M, Weerasinghe D, Weiss V, Collado-Vides J, Gunsalus RP, Paulsen I, Karp PD. 2013. EcoCyc: fusing model organism databases with systems biology. Nucleic Acids Res 41:D605–D612. http://dx.doi.org/10.1093/nar/gks1027.
24. Bryan LE, Van Den Elzen HM. 1977. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother 12:163–177. http://dx.doi.org/10.1128/AAC.12.2.163.
25. Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. 2006. The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci U S A 103:10420–10425. http://dx.doi.org/10.1073/pnas.0604343103.
26. Belas R. 2014. Biofilms, flagella, and mechanosensing of surfaces by bacteria. Trends Microbiol 22:517–527. http://dx.doi.org/10.1016/j.tim.2014.05.002.
27. Terashima H, Kojima S, Homma M. 2008. Flagellar motility in bacteria structure and function of flagellar motor. Int Rev Cell Mol Biol 270: 39–85. http://dx.doi.org/10.1016/S1937-6448(08)01402-0.
28. Macnab RM. 1992. Genetics and biogenesis of bacterial flagella. Annu Rev Genet 26:131–158. http://dx.doi.org/10.1146/annurev.ge.26.120192.001023.
29. Maisonneuve E, Castro-Camargo M, Gerdes K. 2013. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154:1140–1150. http://dx.doi.org/10.1016/j.cell.2013.07.048.
30. Theodore A, Lewis K, Vulic M. 2013. Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway. Genetics 195:1265–1276. http://dx.doi.org/10.1534/genetics.113.152306.
31. Wright KJ, Seed PC, Hultgren SJ. 2005. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 73: 7657–7668. http://dx.doi.org/10.1128/IAI.73.11.7657-7668.2005.
32. Laubacher ME, Ades SE. 2008. The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance. J Bacteriol 190:2065–2074. http://dx.doi.org/10.1128/JB.01740-07.
33. Vega NM, Allison KR, Khalil AS, Collins JJ. 2012. Signaling-mediated bacterial persister formation. Nat Chem Biol 8:431-433. http://dx.doi.org/10.1038/nchembio.915.
34. Ezraty B, Vergnes A, Banzhaf M, Duverger Y, Huguenot A, Brochado AR, Su SY, Espinosa L, Loiseau L, Py B, Typas A, Barras F. 2013. Fe-S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway. Science 340:1583–1587. http://dx.doi.org/10.1126/science.1238328.
35. Goltermann L, Good L, Bentin T. 2013. Chaperonins fight aminoglycoside-induced protein misfolding and promote short-term tolerance in Escherichia coli. J Biol Chem 288:10483–10489. http://dx.doi.org/10.1074/jbc.M112.420380.
36. Moyed HS, Bertrand KP. 1983. Hipa, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155:768–775.
37. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2:2006.0008. http://dx.doi.org/10.1038/msb4100050.
38. Neidhardt FC, Bloch PL, Smith DF. 1974. Culture medium for enterobacteria. J Bacteriol 119:736–747.
39. Klein BA, Tenorio EL, Lazinski DW, Camilli A, Duncan MJ, Hu LT. 2012. Identification of essential genes of the periodontal pathogen Porphyromonas gingivalis. BMC Genomics 13:578. http://dx.doi.org/10.1186/1471-2164-13-578.
40. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. http://dx.doi.org/10.1186/gb-2009-10-3-r25.
41. Andrews JM. 2001. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48(Suppl 1):5–16. http://dx.doi.org/10.1093/jac/48.suppl_1.5.
42. Saito H, Inui K, Hori R. 1986. Mechanisms of gentamicin transport in kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 238:1071–1076.